Page last updated: 2024-12-06

triisopropanolamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

triisopropanolamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID24730
CHEMBL ID1877948
CHEBI ID170017
SCHEMBL ID28985
MeSH IDM0157846

Synonyms (67)

Synonym
LS-13727
1-[bis(2-hydroxypropyl)amino]propan-2-ol
CHEBI:170017
tris(2-hydroxypropyl)amine
tris(2-hydroxy-1-propyl)amine
3,3''-nitrilotri(2-propanol)
wln: qy1 & 1n1yq1 & 1yq1
2-propanol,1',1''-nitrilotri-
triisopropanolamine
tris(2-propanol)amine
122-20-3
tri-iso-propanolamine
nsc-4010
nsc4010
tri-2-propanolamine
2-propanol,1',1''-nitrilotris-
1,1''-nitrilotri-2-propanol
1,1''-nitrilotris(2-propanol)
1,1',1''-nitrilotripropan-2-ol
2-propanol, 1,1',1''-nitrilotris-
2-propanol, 1,1',1''-nitrilotri-
nsc 4010
einecs 204-528-4
1,1',1''-nitrilotri-2-propanol
ai3-01450
ccris 4884
hsdb 5593
brn 1071570
caswell no. 891
epa pesticide chemical code 004209
1,1',1''-nitrilotris(2-propanol)
triisopropanolamine, 95%
NCGC00164112-01
FT-0695343
NCGC00164112-02
w9en9dlm98 ,
unii-w9en9dlm98
4-04-00-01680 (beilstein handbook reference)
ec 204-528-4
3,3',3''-nitrilotri(2-propanol)
dtxsid5021415 ,
tox21_302748
cas-122-20-3
dtxcid201415
NCGC00256448-01
tox21_201952
NCGC00259501-01
AKOS015965047
triisopropanolamin
1,1',1''-nitrilotris-2-propanol
tris(2-hydroxypropyl)amine [hsdb]
triisopropanolamine [inci]
unichem tipa
SCHEMBL28985
tris-(2-hydroxypropyl)amine
1,1',1''-nitrilotris[2-propanol]
trisisopropanolamine
tris(isopropanol)amine
J-660022
CHEMBL1877948
mfcd00004533
CS-W010723
1,1',1''-nitrilotris(propan-2-ol)
Q1729503
D70439
1,1',1''-nitrilotri(-2-propanol)
EN300-8108474

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In the present study, safe and effective ionic liquids for transdermal absorption were obtained as salts generated by a neutralization reaction between highly biocompatible aliphatic carboxylic acids (octanoic acid or isostearic acid) and aliphatic amines (diisopropanolamine or triisopropanolamine) (Medrx Co."( The molecular assembly of the ionic liquid/aliphatic carboxylic acid/aliphatic amine as effective and safety transdermal permeation enhancers.
Kubota, K; Shibata, A; Yamaguchi, T, 2016
)
0.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amino alcoholAn alcohol containing an amino functional group in addition to the alcohol-defining hydroxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency63.57060.002541.796015,848.9004AID1347395
GLI family zinc finger 3Homo sapiens (human)Potency24.43550.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency0.00200.000221.22318,912.5098AID588515
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency54.70440.003041.611522,387.1992AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency31.98920.001530.607315,848.9004AID1224841; AID1259401
estrogen nuclear receptor alphaHomo sapiens (human)Potency16.16630.000229.305416,493.5996AID743069; AID743075; AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00140.023723.228263.5986AID588543
thyroid stimulating hormone receptorHomo sapiens (human)Potency19.40980.001628.015177.1139AID1224843
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency54.48270.000627.21521,122.0200AID651741; AID743202
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.21 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index71.42 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]